These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 21959072)

  • 1. Possible role of serotonin transporter in irritable bowel syndrome: evidence from platelet investigation.
    Franke L; Schmidtmann M; Mönnikes H
    Gastroenterology; 2011 Nov; 141(5):e18-9; author reply e19. PubMed ID: 21959072
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired uptake of serotonin by platelets from patients with irritable bowel syndrome correlates with duodenal immune activation.
    Foley S; Garsed K; Singh G; Duroudier NP; Swan C; Hall IP; Zaitoun A; Bennett A; Marsden C; Holmes G; Walls A; Spiller RC
    Gastroenterology; 2011 May; 140(5):1434-43.e1. PubMed ID: 21315720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review article: intestinal serotonin signalling in irritable bowel syndrome.
    Mawe GM; Coates MD; Moses PL
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1067-76. PubMed ID: 16611266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome.
    Jovani M; Fiorino G; Danese S
    Aliment Pharmacol Ther; 2013 Jan; 37(2):277-8. PubMed ID: 23252779
    [No Abstract]   [Full Text] [Related]  

  • 5. Confocal endomicroscopy shows food-associated changes in the intestinal mucosa of patients with irritable bowel syndrome.
    Fritscher-Ravens A; Schuppan D; Ellrichmann M; Schoch S; Röcken C; Brasch J; Bethge J; Böttner M; Klose J; Milla PJ
    Gastroenterology; 2014 Nov; 147(5):1012-20.e4. PubMed ID: 25083606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Commentary: associations between immune activation, intestinal permeability and irritable bowel syndrome - author's reply.
    Matricon J
    Aliment Pharmacol Ther; 2013 Jan; 37(2):278-9. PubMed ID: 23252780
    [No Abstract]   [Full Text] [Related]  

  • 7. IBS: Jejunal humoral immunity in diarrhoea-predominant IBS.
    Patman G
    Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):643. PubMed ID: 25266111
    [No Abstract]   [Full Text] [Related]  

  • 8. Irritable bowel syndrome and the elusive mast cells.
    Theoharides TC; Asadi S; Chen J; Huizinga JD
    Am J Gastroenterol; 2012 May; 107(5):727-9. PubMed ID: 22552242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of irritable bowel syndrome: the mast cell connection.
    Santos J; Guilarte M; Alonso C; Malagelada JR
    Scand J Gastroenterol; 2005 Feb; 40(2):129-40. PubMed ID: 15764142
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.
    Jin DC; Cao HL; Xu MQ; Wang SN; Wang YM; Yan F; Wang BM
    World J Gastroenterol; 2016 Sep; 22(36):8137-48. PubMed ID: 27688655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mast cells in irritable bowel syndrome and ulcerative colitis: function not numbers is what makes all the difference.
    Theoharides TC
    Dig Dis Sci; 2014 May; 59(5):897-8. PubMed ID: 24445729
    [No Abstract]   [Full Text] [Related]  

  • 12. Review article: Associations between immune activation, intestinal permeability and the irritable bowel syndrome.
    Matricon J; Meleine M; Gelot A; Piche T; Dapoigny M; Muller E; Ardid D
    Aliment Pharmacol Ther; 2012 Dec; 36(11-12):1009-31. PubMed ID: 23066886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editorial: abnormal permeability and altered mucosal serotonin metabolism in the irritable bowel syndrome - is there a link?
    Spiller R
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1116-8. PubMed ID: 25280258
    [No Abstract]   [Full Text] [Related]  

  • 14. Histamine, 5-hydroxytriptamine, collagen, mast cells and Ig-secreting cells in the small bowel disorders with diarrhea.
    Stoianov SG; Penchev PI; Gerova VA; Tsenova VG
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):486-7. PubMed ID: 19104721
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon-γ is increased in the gut of patients with irritable bowel syndrome and modulates serotonin metabolism.
    Barbaro MR; Di Sabatino A; Cremon C; Giuffrida P; Fiorentino M; Altimari A; Bellacosa L; Stanghellini V; Barbara G
    Am J Physiol Gastrointest Liver Physiol; 2016 Mar; 310(6):G439-47. PubMed ID: 26744473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritable bowel syndrome: is the colonic mucosa to blame?
    Hoffman JM
    Neurogastroenterol Motil; 2012 Dec; 24(12):1051-3. PubMed ID: 23176660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal barrier defects in irritable bowel syndrome. Who left the door open?
    Barbara G
    Am J Gastroenterol; 2006 Jun; 101(6):1295-8. PubMed ID: 16771952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status.
    Houghton LA; Brown H; Atkinson W; Morris J; Fell C; Whorwell PJ; Lockhart S; Keevil B
    Aliment Pharmacol Ther; 2009 Nov; 30(9):919-29. PubMed ID: 19691669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter gene polymorphisms in Southwestern Iranian patients with irritable bowel syndrome.
    Farjadian S; Fakhraei B; Moeini M; Nasiri M; Fattahi MR
    Arab J Gastroenterol; 2013 Jun; 14(2):59-62. PubMed ID: 23820502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.
    Vicario M; González-Castro AM; Martínez C; Lobo B; Pigrau M; Guilarte M; de Torres I; Mosquera JL; Fortea M; Sevillano-Aguilera C; Salvo-Romero E; Alonso C; Rodiño-Janeiro BK; Söderholm JD; Azpiroz F; Santos J
    Gut; 2015 Sep; 64(9):1379-88. PubMed ID: 25209656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.